Sonder Holdings Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Sonder Holdings Inc. (“Sonder” or the “Company”) (NASDAQ: SOND). Click here to join the investigation…. Read MoreJoin Investigation
Shoals Technologies Group, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers of Shoals Technologies Group, Inc. (“Shoals” or the “Company”) common stock (NASDAQ: SHLS) between May 17, 2022 and November 8, 2023 (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation
Checkpoint Therapeutics, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT) securities between March 10, 2021 and December 15, 2023 (the “Class Period”). Click Here to Join Investigation. … Read MoreJoin Investigation
SSR Mining Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of SSR Mining Inc. (“SSR” or the “Company”)(NASDAQ: SSRM). SSR is a mining company with operations in the United States, Türkiye, Canada and Argentina. Click Here to Join Investigation…. Read MoreJoin Investigation
Luna Innovations Incorporated Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Luna Innovations Incorporated (“Luna” or the “Company”) (NASDAQ: LUNA). Click here to join the investigation…. Read MoreJoin Investigation
The Chemours Company Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”)(NYSE: CC). Click Here To Join Investigation…. Read MoreJoin Investigation
Doximity, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of the common stock of Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) between February 9, 2022 and April 1, 2024 (the “Class Period”)…. Read MoreJoin Investigation
Vestis Corporation Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS)…. Read MoreJoin Investigation